02 July 2025
02 July 2025
Research by non-partisan think-tank CBO forecasts that the bill’s massive cuts to Medicaid could leave 11.8 million Americans without health insurance by 2034.
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some experts.
With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis portfolio.
Merck adds two SpringWorks’ products targeting rare tumours with limited treatment options.
Oncternal folded all clinical trials in September 2024 and has since been exploring strategic alternatives.
Phase IIb HERIZON-BTC-01 trial data supported the EC authorisation.
In Japan alone, around 4,000 individuals have a CIDP diagnosis.
Uruguay’s new left-wing coalition government took office in March 2025, under President Yamandu Orsi.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
